Central nervous system
oxygen toxicity (CNS-OT)
seizures occur with little or no warning, and no effective mitigation strategy has been identified.
Ketogenic diets (KD) elevate blood
ketones and have successfully treated
drug-resistant epilepsy. We hypothesized that a
ketone ester given orally as R,S-1,3-butanediol
acetoacetate diester (BD-AcAc(2)) would delay CNS-OT
seizures in rats breathing hyperbaric
oxygen (HBO(2)). Adult male rats (n = 60) were implanted with radiotelemetry units to measure electroencephalogram (EEG). One week postsurgery, rats were administered a single oral dose of BD-AcAc(2),
1,3-butanediol (BD), or water 30 min before being placed into a hyperbaric chamber and pressurized to 5 atmospheres absolute (ATA) O2. Latency to seizure (LS) was measured from the time maximum pressure was reached until the onset of increased EEG activity and tonic-clonic contractions. Blood was drawn at room pressure from an arterial
catheter in an additional 18 animals that were administered the same compounds, and levels of
glucose, pH, Po(2), Pco(2), β-hydroxybutyrate (BHB),
acetoacetate (AcAc), and
acetone were analyzed. BD-AcAc(2) caused a rapid (30 min) and sustained (>4 h) elevation of BHB (>3 mM) and AcAc (>3 mM), which exceeded values reported with a KD or
starvation. BD-AcAc(2) increased LS by 574 ± 116% compared with control (water) and was due to the effect of AcAc and
acetone but not BHB. BD produced
ketosis in rats by elevating BHB (>5 mM), but AcAc and
acetone remained low or undetectable. BD did not increase LS. In conclusion, acute
oral administration of BD-AcAc(2) produced sustained
ketosis and significantly delayed CNS-OT
seizures by elevating AcAc and
acetone.